Company RegeneRx Biopharmaceuticals Inc OTC Bulletin Board

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Biopharmaceuticals

Inactive Instrument

RegeneRx Biopharmaceuticals, Inc. (RegeneRx) is a biopharmaceutical company. The RegeneRx is focused on the development of a therapeutic peptide Thymosin beta 4(Tb4) for tissue and organ protection, repair, and regeneration. RegeneRx operates in the development and marketing of Tb4, an amino acid peptide. Tb4 is a synthetic copy of a naturally occurring 43-amino acid peptid originally isolated from bovine thymus glands. The Company's product candidates in clinical development includes RGN-259, RGN-352, and RGN-137. The Company's RGN -259 is a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease or other pathology. RGN-352 is an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases. Its RGN-137 is a topical gel for dermal wounds and reduction of scar tissue.

USD in Million	2021	Weight	2022	Weight	Delta
Novel Molecules 100.0 %	0	100.0 %	0	100.0 %	-.--%

USD in Million	2021	Weight	2022	Weight	Delta
United States 100.0 %	0	100.0 %	0	100.0 %	-.--%

Managers	Title	Age	Since
Allan L. Goldstein FOU	Founder	86	82-05-12
J. Finkelstein CEO	Chief Executive Officer	72	83-12-31

Members of the board	Title	Age	Since
J. Finkelstein CEO	Chief Executive Officer	72	83-12-31
Allan L. Goldstein FOU	Founder	86	82-05-12
Joe McNay BRD	Director/Board Member	90	01-12-31
Mauro Bove BRD	Director/Board Member	69	03-12-31
R. Elsey BRD	Director/Board Member	71	10-08-31
Alessandro Noseda BRD	Director/Board Member	66	19-03-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,496,966	836,249 ( 55.86 %)	0	55.86 %

Name	Equities	%	Valuation
Essetifin SpA 24.38 %	364,891	24.38 %	365 $
HLB THERAPEUTICS CO.,LTD. 13.08 %	195,833	13.08 %	196 $
Joe McNay 4.358 %	65,241	4.358 %	65 $
J. Finkelstein 1.182 %	17,692	1.182 %	18 $
Allan L. Goldstein 1.070 %	16,015	1.070 %	16 $
R. Elsey 0.0698 %	1,045	0.0698 %	1 $
Mauro Bove 0.000000 %	0	0.000000 %	- $
Alessandro Noseda 0.000000 %	0	0.000000 %	- $

RegeneRx Biopharmaceuticals, Inc.

15245 Shady Grove Road Suite 470

20850, Rockville

http://www.regenerx.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
CSL LIMITED	-2.52%	85.68B
SAMSUNG BIOLOGICS CO.,LTD.	+4.08%	41.4B
BIOGEN INC.	-25.35%	28.22B
UCB	+54.31%	24.64B
BIOMARIN PHARMACEUTICAL INC.	-4.52%	16.98B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42.09%	13.29B
INCYTE CORPORATION	-17.77%	11.66B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.10%	11.65B
SWEDISH ORPHAN BIOVITRUM AB	+0.75%	8.18B